Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) plans to raise no more than 700 million yuan in a private placement.

Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) announced that it plans to issue A shares to a specific entity, Guizhou Cenli Technology Co., Ltd. (referred to as "Cenli Technology," to be established), with Cenli Technology intending to subscribe to the shares with cash. As of the announcement of this proposal, Cenli Technology (to be established) is 100% owned by the company's controlling shareholder and actual controller, Zhang Hai. The number of A shares to be issued to the specific entity in this issuance does not exceed 123 million shares, with a total fundraising amount of no more than 700 million yuan, including issuing expenses. The net proceeds from the fundraising, after deducting the issuance expenses, are intended to be used entirely for supplementing working capital and repaying bank loans.